Malignant gliomas often demonstrate a marked upregulation of vascular endothelial growth factor and other angiogenic markers, including vascular integrins, rendering them potentially susceptible to antiangiogenic therapies [1, 29]. Here, VEGFA is linked to malignant glioma.